Revvity Inc. (NYSE:RVTY – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $125.97 and last traded at $124.9360, with a volume of 51126 shares. The stock had previously closed at $124.84.
More Revvity News
Here are the key news stories impacting Revvity this week:
- Positive Sentiment: Zacks Research raised its FY2026 EPS forecast to $5.38 from $5.25, slightly above the $5.36 consensus estimate. The firm also increased its FY2027 forecast to $5.86 from $5.77, while lifting Q1 2027 EPS to $1.17 and Q4 2027 EPS to $1.77. These revisions suggest improving expectations for longer-term earnings growth. Revvity analyst estimates
- Neutral Sentiment: Zacks maintained a Hold rating, limiting the bullish impact of the higher estimates. Revvity’s latest reported quarter also exceeded expectations, with EPS of $1.41 versus the $1.21 consensus and revenue of $729.7 million versus $703.0 million, although revenue declined 1.3% year over year.
- Neutral Sentiment: An analysis highlighted that Revvity faces a new test after its strong advance. With the shares near their annual high, investors may focus on whether future operating improvement can justify the recent valuation and momentum. Revvity faces a new test after its strong run
- Negative Sentiment: Zacks lowered several quarterly forecasts, including Q3 2026 EPS to $1.27 from $1.30, Q4 2026 EPS to $1.64 from $1.67, Q3 2027 EPS to $1.42 from $1.44, and Q2 2028 EPS to $1.62 from $1.64. The cuts indicate some uncertainty around near-term earnings momentum.
Analysts Set New Price Targets
A number of research firms have recently commented on RVTY. JPMorgan Chase & Co. lowered their target price on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Wolfe Research assumed coverage on shares of Revvity in a research report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Stifel Nicolaus decreased their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Sanford C. Bernstein assumed coverage on shares of Revvity in a research report on Friday, June 26th. They set a “market perform” rating and a $115.00 price objective for the company. Finally, Robert W. Baird set a $117.00 price objective on shares of Revvity in a research note on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $108.36.
Revvity Stock Performance
The firm has a market capitalization of $14.43 billion, a PE ratio of 61.57, a P/E/G ratio of 2.30 and a beta of 1.07. The business has a 50-day simple moving average of $113.52 and a 200-day simple moving average of $101.02. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50.
Revvity (NYSE:RVTY – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. The firm had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The company’s quarterly revenue was down 1.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts expect that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.
Revvity Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s payout ratio is presently 13.33%.
Institutional Investors Weigh In On Revvity
Several hedge funds and other institutional investors have recently made changes to their positions in the company. California State Teachers Retirement System lifted its stake in Revvity by 19.8% in the first quarter. California State Teachers Retirement System now owns 133,809 shares of the company’s stock worth $11,723,000 after purchasing an additional 22,075 shares during the last quarter. Corient Private Wealth LLC grew its stake in shares of Revvity by 985.0% during the fourth quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock valued at $12,245,000 after buying an additional 114,903 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of Revvity in the second quarter worth approximately $78,766,000. Diamond Hill Capital Management Inc. raised its holdings in shares of Revvity by 6.3% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock worth $41,302,000 after buying an additional 25,233 shares during the period. Finally, First National Bank of Omaha bought a new stake in shares of Revvity during the 2nd quarter worth approximately $3,908,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.
Revvity Company Profile
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
See Also
- Five stocks we like better than Revvity
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
